Roche Products Pty Limited (Australia) is part of the International F. Hoffmann-La Roche Group worldwide that was founded in 1896 in Basel, Switzerland. Roche has grown from a small drug laboratory into one of the world's leading research-based Healthcare companies and is known for many innovative contributions to medicine.
In Australia, Roche Product's Pharmaceuticals Division forms the core of all Roche's operations, accounting for over 50 per cent of the Roche Group's sales and employing over 30 thousand people worldwide.
Over the last few years, by focusing its efforts on innovation and efficiency, the Pharmaceuticals Division has consistently improved its ability to develop novel drugs, launch them quickly worldwide, and achieve a leading position in major therapeutic areas.
Roche's acquisition of a majority holding in California-based Genentech, one of the world's leading biotechnology companies, has also contributed to this. In addition, the Division pursues a strategy of collaboration with other research-based companies and academic institutions to gain access both to new products and new technologies. The resulting distribution of sales across a broader product base makes it possible to sustain research and development on innovative products that offer real improvements to doctors, hospitals and patients.
Roche Products Pty Limited has been committed to improving the health and well-being of people in Australia from birth to old age for more than 50+ years. Our aim is to enhance the quality of life for everyone.
|
